Rahem Rahmati: Toxic Epidermal Necrolysis in a Pregnant IVF Patient on Hydroxychloroquine
Rahem Rahmati, Executive Secretary at Student Research and Technology Committee, shared a post on LinkedIn about a paper published in Clinical Case Reports:
“A reminder that even established treatments can have rare, severe consequences.
Our latest case report details a pregnant IVF patient who developed life-threatening Toxic Epidermal Necrolysis (TEN) after taking hydroxychloroquine for recurrent implantation failure.
Title: Toxic Epidermal Necrolysis and Recurrent Implantation Failure: Unveiling a Rare Phenomenon During Pregnancy
Authors: Hatav Ghasemi Tehrani, Faezeh Zakerinasab, Negar Khalili Geshnigani, Rahem Rahmati, Nastaran Zamani Dehkordi
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 21, 2025, 06:53New Guidelines on Frozen Embryo Transfer Released – RBMO
-
Dec 21, 2025, 06:32What is JAMA+ Women’s Health? – JAMA+ Women’s Health
-
Dec 21, 2025, 06:20Contraceptive Use and Ovarian Reserve Interactions – Fertility and Sterility
-
Dec 21, 2025, 02:55Epigenetic Links Between Paternal Age, Reproduction and Offspring Health – Reproduction and Fertility
-
Dec 21, 2025, 02:43Medicines and Pregnancy: ANSM Proposes New Labeling – B’RIGHT
-
Dec 21, 2025, 02:28Steven Palter: It is time to retire the out of date ‘2 week wait’ for pregnancy tests after IVF
-
Dec 21, 2025, 02:24Thorsten Waloschek: New Study Highlights Preeclampsia Risk Stratification Benefits
-
Dec 21, 2025, 02:15Siddhartha Yadav: New ASCO Guideline for Managing Cancer During Pregnancy
-
Dec 21, 2025, 01:56New Patient Resource on Thyroid Issues in Pregnancy – RCOG